Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 13, 2014 10:25:58 AM
1) Lack of profitability
2) Excessive dilution of stock price
3) Sec investigation
Whenever these 3 are gone...which could be next month....then the sky is the limit...until then $18 is most likely the limit.
I think the first ghost is gone already as Musclepharm most likely will be posting profits going forward. A guidance that doesn't understate reality would indicate less dilution. If management wants to dilute, it wants to announce a huge jump in earnings AFTER announcing a highly dilutive employees incentives plan.
Working hard on getting concluded the SEC investigation would in itself prove that management wants to act like a Nasdaq listed company, and not like the Fed or bank of Japan, Argentina...printing money.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM